Cargando…

Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling

BACKGROUND: Long noncoding RNAs (lncRNAs) have been indicated to play critical roles in cancer development and progression. LncRNA HOXD cluster antisense RNA1 (HOXD-AS1) has recently been found to be dysregulated in several cancers. However, the expression levels, cellular localization, precise func...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Min-Hui, Zhao, Li, Wang, Lan, Ou-Yang, Wen, Hu, Sha-Sha, Li, Wen-Lu, Ai, Mei-Ling, Wang, Yi-Qing, Han, Yue, Li, Ting-Ting, Ding, Yan-Qing, Wang, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397497/
https://www.ncbi.nlm.nih.gov/pubmed/30823921
http://dx.doi.org/10.1186/s12943-019-0955-9
_version_ 1783399429080875008
author Yang, Min-Hui
Zhao, Li
Wang, Lan
Ou-Yang, Wen
Hu, Sha-Sha
Li, Wen-Lu
Ai, Mei-Ling
Wang, Yi-Qing
Han, Yue
Li, Ting-Ting
Ding, Yan-Qing
Wang, Shuang
author_facet Yang, Min-Hui
Zhao, Li
Wang, Lan
Ou-Yang, Wen
Hu, Sha-Sha
Li, Wen-Lu
Ai, Mei-Ling
Wang, Yi-Qing
Han, Yue
Li, Ting-Ting
Ding, Yan-Qing
Wang, Shuang
author_sort Yang, Min-Hui
collection PubMed
description BACKGROUND: Long noncoding RNAs (lncRNAs) have been indicated to play critical roles in cancer development and progression. LncRNA HOXD cluster antisense RNA1 (HOXD-AS1) has recently been found to be dysregulated in several cancers. However, the expression levels, cellular localization, precise function and mechanism of HOXD-AS1 in colorectal carcinoma (CRC) are largely unknown. METHODS: Real-time PCR and in situ hybridization were used to detect the expression of HOXD-AS1 in CRC tissue samples and cell lines. Gain- and loss-of-function experiments were performed to investigate the biological roles of HOXD-AS1 in CRC cell line. RNA pull down, RNA immunoprecipitation and chromatin immunoprecipitation assays were conducted to investigate the mechanisms underlying the functions of HOXD-AS1 in CRC. RESULTS: We observed that HOXD-AS1 was located in the nucleus of CRC cells and that nuclear HOXD-AS1 was downregulated in most CRC specimens and cell lines. Lower levels of nuclear HOXD-AS1 expression were associated with poor outcomes of CRC patients. HOXD-AS1 downregulation enhanced proliferation and migration of CRC cells in vitro and facilitated CRC tumourigenesis and metastasis in vivo. Mechanistic investigations revealed that HOXD-AS1 could suppress HOXD3 transcription by recruiting PRC2 to induce the accumulation of the repressive marker H3K27me3 at the HOXD3 promoter. Subsequently, HOXD3, as a transcriptional activator, promoted Integrin β3 transcription, thereby activating the MAPK/AKT signalling pathways. CONCLUSION: Our results reveal a previously unrecognized HOXD-AS1-HOXD3-Integrin β3 regulatory axis involving in epigenetic and transcriptional regulation constitutes to CRC carcinogenesis and progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-019-0955-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6397497
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63974972019-03-13 Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling Yang, Min-Hui Zhao, Li Wang, Lan Ou-Yang, Wen Hu, Sha-Sha Li, Wen-Lu Ai, Mei-Ling Wang, Yi-Qing Han, Yue Li, Ting-Ting Ding, Yan-Qing Wang, Shuang Mol Cancer Research BACKGROUND: Long noncoding RNAs (lncRNAs) have been indicated to play critical roles in cancer development and progression. LncRNA HOXD cluster antisense RNA1 (HOXD-AS1) has recently been found to be dysregulated in several cancers. However, the expression levels, cellular localization, precise function and mechanism of HOXD-AS1 in colorectal carcinoma (CRC) are largely unknown. METHODS: Real-time PCR and in situ hybridization were used to detect the expression of HOXD-AS1 in CRC tissue samples and cell lines. Gain- and loss-of-function experiments were performed to investigate the biological roles of HOXD-AS1 in CRC cell line. RNA pull down, RNA immunoprecipitation and chromatin immunoprecipitation assays were conducted to investigate the mechanisms underlying the functions of HOXD-AS1 in CRC. RESULTS: We observed that HOXD-AS1 was located in the nucleus of CRC cells and that nuclear HOXD-AS1 was downregulated in most CRC specimens and cell lines. Lower levels of nuclear HOXD-AS1 expression were associated with poor outcomes of CRC patients. HOXD-AS1 downregulation enhanced proliferation and migration of CRC cells in vitro and facilitated CRC tumourigenesis and metastasis in vivo. Mechanistic investigations revealed that HOXD-AS1 could suppress HOXD3 transcription by recruiting PRC2 to induce the accumulation of the repressive marker H3K27me3 at the HOXD3 promoter. Subsequently, HOXD3, as a transcriptional activator, promoted Integrin β3 transcription, thereby activating the MAPK/AKT signalling pathways. CONCLUSION: Our results reveal a previously unrecognized HOXD-AS1-HOXD3-Integrin β3 regulatory axis involving in epigenetic and transcriptional regulation constitutes to CRC carcinogenesis and progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-019-0955-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-01 /pmc/articles/PMC6397497/ /pubmed/30823921 http://dx.doi.org/10.1186/s12943-019-0955-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yang, Min-Hui
Zhao, Li
Wang, Lan
Ou-Yang, Wen
Hu, Sha-Sha
Li, Wen-Lu
Ai, Mei-Ling
Wang, Yi-Qing
Han, Yue
Li, Ting-Ting
Ding, Yan-Qing
Wang, Shuang
Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
title Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
title_full Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
title_fullStr Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
title_full_unstemmed Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
title_short Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
title_sort nuclear lncrna hoxd-as1 suppresses colorectal carcinoma growth and metastasis via inhibiting hoxd3-induced integrin β3 transcriptional activating and mapk/akt signalling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397497/
https://www.ncbi.nlm.nih.gov/pubmed/30823921
http://dx.doi.org/10.1186/s12943-019-0955-9
work_keys_str_mv AT yangminhui nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT zhaoli nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT wanglan nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT ouyangwen nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT hushasha nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT liwenlu nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT aimeiling nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT wangyiqing nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT hanyue nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT litingting nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT dingyanqing nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling
AT wangshuang nuclearlncrnahoxdas1suppressescolorectalcarcinomagrowthandmetastasisviainhibitinghoxd3inducedintegrinb3transcriptionalactivatingandmapkaktsignalling